case_images: PMC7448234_01
case_images: Preoperative imaging demonstrating a large tumour displacing the liver.
case_images: CRIONM2020-9805847.001.jpg
case_images: PMC7448234_01_CRIONM2020-9805847.001.jpg
case_images: fig1
case_images: Computed tomography (CT) demonstrated a large tumour measuring 17.5 cm x 15.9 cm displacing the liver (Figure 1).
case_images: (a) H&E section of the tumour. (b) Tumour cells stained with glial fibrillary acid protein.
case_images: CRIONM2020-9805847.002.jpg
case_images: PMC7448234_01_CRIONM2020-9805847.002.jpg
case_images: fig2
case_images: The tumour was cellular consisting of elongated tumour cells with oval, mildly pleomorphic nuclei (Figure 2). Mitotic figures were rare (Figure 2(a), H&E section, x100). These tumour cells were immunoreactive to glial fibrillary acid protein (GFAP, Figure 2(b), x200).
case_images: (a) Chest radiograph before thoracic radiotherapy. (b) Chest radiograph 4 months after thoracic radiotherapy.
case_images: CRIONM2020-9805847.003.jpg
case_images: PMC7448234_01_CRIONM2020-9805847.003.jpg
case_images: fig3
case_images: The radiotherapy led to a marked reduction in tumour size and improvement in symptoms within 4 months after the initial radiotherapy (Figure 3).